arrow
Back
J

Jie Jin

The First Affiliated Hospital

60H-index
1.3KPaper Count
1.9WCitation Count
Published Papers 310
Publication Date
Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
err2026-07-27
err0
errOAAI
errChenying Li; Hongyan Tong; Huafeng Wang; Yanling Ren; Jiejing Qian; Xinping Zhou; Gaixiang Xu; Liangshun You; Liping Mao; Haitao Meng; Wenjuan Yu; Xingnong Ye; Min Yang; Jian Huang; De Zhou; Wanzhuo Xie; Jie Jin; Yinjun Lou
errShare
errSave
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group
err2026-05-26
err0
PREAI
errJiajia Pan; Chunmei Fu; Qing Ling; Ying Lu; Yifen Shi; Yunxiang Zhang; Shaoyuan Wang; Chunyan Ji; Shenxian Qian; Zhenqi Huang; Zheng Ge; Jingcheng Zhang; Guifang Ouyang; Chenghao Jin; Quanyi Lu; Li Huang; Hongwei Kong; Yu Zhu; Zhiling Yan; Debin Liu; Huawei Jiang; Nianci Chen; Xiangjie Lin; Yile Zhou; Yi Zhang; Xia Li; Hongyan Tong; Jie Jin; Suning Chen; Huafeng Wang; East China Leukemia Alliance
errShare
errSave
Mutation Profiling, Efficacy Monitoring, and Prognosis Evaluation Using Circulating Tumor DNA in Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Observational Study
err2026-05-21
err0
errOAAI
errZhao Donglu; Song Yuqin; Qin Jiayue; Tong Hongyan; Ding Kaiyang; Cai Qingqing; Huang Huiqiang; Wu Lili; Jing Hongmei; Zhang Liling; Qian Wenbin; Bai Ou; Cao Shanbo; Jin Jie; Zhu Jun; Ma Jun
errShare
errSave
Finite-Duration Venetoclax/Azacitidine Followed by Umbilical Cord Blood Infusion Improves Outcomes in Frail Elderly Patients With Untreated Acute Myeloid Leukemia—A Pilot Study
err2026-05-19
err0
errOAAI
errLi Ye; Mixue Xie; Gaixiang Xu; Chen Mei; Chao Hu; Xinping Zhou; Yanling Ren; Liya Ma; Chunmei Yang; Jiejing Qian; Jie Jin; Hongyan Tong
errShare
errSave
Harnessing mitohormesis: A thiazole-based mitochondrial respiration inhibitor restores metabolic homeostasis in type 2 diabetes
err2026-04-26
err0
PREAI
errYang Zhang; Jie Guo; Jie Jin; Ci-An Cheng; Yixin Hu; Shihao Chen; Chen Wang; Xinwei Meng; Binglu Jiang; Zhihao Jia; Yixue Qiao; Jinxin Gu; David A. Tyvoll; James P. Collman; Lei Fu
errShare
errSave
Combined prognostic impact of complex karyotype and KIT mutations refines risk stratification in t(8;21) acute myeloid leukemia
errCancer
IF5.1
err2026-04-01
err0
PREAI
errLiu, Lin; Shi, Yuanfei; Wang, Lu; Maleki Goli, Maryam; Ghanad, Parnia; Zhao, Shuqi; Xu, Huan; Wang, Dongmei; Qi, Lingling; Wang, Huanping; Chen, Zhimei; Tu, Jifang; Zhou, Junhao; Li, Mengyu; Ruan, Xiaoling; Jin, Jie; Tong, Hongyan
errShare
errSave
Proteomics landscape of early T-cell precursor acute lymphoblastic leukemia reveals deficient oxidative phosphorylation signatures
err2026-02-03
err0
errOAAI
errMiaomiao Liu; Tianyi Chen; Xiangjie Lin; Bowen Wu; Fujie Shi; Junya Liu; Yi Chen; Tao Zeng; Shangyu Hou; Qingfei Pan; Xuemei Wang; Yiyi Yao; Wenyu Yang; Yingchi Zhang; Jinyan Huang; Jie Jin; Yinghui Zhu; Huafeng Wang
errShare
errSave
Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial
err2026-02-01
err2
errOAAI
errMei, Chen; Xu, Gaixiang; Zheng, Cuiping; Xie, Yaping; Li, Minming; Shao, Yanping; Yao, Rongxin; Tao, Shi; Jiang, Wei; Guo, Jun; Zheng, Zhiyin; Wang, Wei; Zhou, Xinping; Ma, Liya; Ye, Li; Luo, Yingwan; Yang, Chunmei; Yu, Wenjuan; Xie, Wanzhuo; Jin, Jie; Tong, Hongyan
errShare
errSave
Structure-guided discovery of cholic acid derivatives as potent and selective TGR5 allosteric agonists for the treatment of diabetes
err2025-12-16
err0
PREAI
errXuemei Shao; Qirong Cao; Jingjing Sun; Jie Jin; Jisheng Li; Chentao Hua; Zhijie Luo; Shuai Zhao; Yanan Hou; Xin Chen; Mingcheng Qian
errShare
errSave
Venetoclax and Homoharringtonine-Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T-Cell Precursor Acute Lymphoblastic Leukemia
errMEDCOMM
IF10.7
err2025-12-12
err0
errOAAI
errZhang, Xiang; Zhou, Hongsheng; Mao, Liping; Lou, Yinjun; Shen, Lijing; Lu, Ying; Liu, Zhenfang; Tong, Xiuzhen; Zhang, Aiping; Liu, Tingbo; Zhang, Na; Ye, Xingnong; Wei, Juying; Luo, Meihong; Wang, Shaoyuan; Bai, Qingxian; Hou, Jian; Liu, Qifa; Tong, Hongyan; Jin, Jie; Yu, Wenjuan
errShare
errSave
Pru p 7 Sensitisation in Northern China: High Prevalence and Wide Cross-Reactivity
err2025-12-12
err0
errOAAI
errJing Jin; Bingjie Chen; Siqin Wang; Jianbo Wang; Pengfei Ba; Lan Zhao; Bingyang Zhou; Jie Jin; Xu Wang; Zhongshan Gao; Jinyong Huang
errShare
errSave
Evaluation of iMS-IP assay for the detection and typing of monoclonal immunoglobulins
err2025-12-01
err0
PREAI
errYu Chen; Liangshun You; Li Zhu; Xuejiao Yin; Qiumei Yao; Shengnan Ding; Jiaying Ge; Yi Liu; Hongyan Tong; Jie Jin; Haitao Meng; Min Yang
errShare
errSave
Integrated prognostic value of MRD and cytogenetics in adolescent and adult B-cell acute lymphoblastic leukaemia
err2025-12-01
err0
PREAI
errGu, Jiayan; Wang, Jinghan; Liu, Lin; Zhang, Yi; Ghanad, Parnia; Goli, Maryam Maleki; Bao, Chenhui; Jin, Jie; Tong, Hongyan
errShare
errSave
Allogeneic hematopoietic stem cell transplantation abrogates the poor prognosis of high-risk cytogenetics in adult Philadelphia-negative B-cell acute lymphoblastic leukemia
err2025-11-03
err0
PREAI
errLin Liu; Jiayan Gu; Lu Wang; Maryam Maleki Goli; Parnia Ghanad; Huan Xu; Shuqi Zhao; Bingqian Jiang; Dongmei Wang; Lingling Qi; Huanping Wang; Zhimei Chen; Jifang Tu; Junhao Zhou; Mengyu Li; Jie Jin; Hongyan Tong
errShare
errSave
Glofitamab combined with tislelizumab in relapsed/refractory diffuse large B-cell lymphoma: a single-center pilot trial
err2025-11-01
err0
errOAAI
errDe Zhou; Wenjuan Yu; Mixue Xie; Ehsan Ghoushi; Xuelian Hu; Xin Huang; Juying Wei; Xingnong Ye; Xiaolong Zheng; Jie Jin; Wanzhuo Xie; Hongyan Tong
errShare
errSave
Efficacy and safety of OB756 (a novel selective JAK2 inhibitor) for essential thrombocythemia in patients intolerant of or resistant to hydroxyurea or intolerant of interferon: A phase 2, open-label, multicenter study
errCancer
IF5.1
err2025-10-08
err0
PREAI
errJian Huang MD; Rumeng Li MSc; Tiejun Gong MSc; Pengxiang Guo MSc; Lihong Shou MSc; Hu Zhou MD; Zongjiu Jiao MSc; Feng Zhang MSc; Qinchi Liu MSc; Lidong Zhao MSc; Guocai Wu MSc; Lili Chen MSc; Yile Zhou MD; Yi Zhang MD; Jie Jin PhD
errShare
errSave